通化金马拟以7000万元设立全资子公司，加强开展创新药产业的并购和布局

Core Viewpoint - Tonghua Golden Horse plans to invest 70 million yuan to establish a wholly-owned subsidiary, Guilin Jinma Innovation Investment Co., Ltd, to enhance its strategic focus on innovation-driven development in the pharmaceutical industry [1] Group 1: Investment and Strategic Development - The investment of 70 million yuan will be sourced from the company's own or raised funds [1] - The establishment of the subsidiary aligns with the company's strategy to transform into an innovation-driven modern pharmaceutical enterprise [1] - The move aims to strengthen the company's capabilities in mergers and acquisitions within the innovative drug sector, thereby enhancing its core competitiveness [1] Group 2: Long-term Sustainability - The initiative is intended to inject new momentum into the company's long-term sustainable development [1]